Akebia Therapeutics Inc (AKBA)
1.33
0.00 (0.00%)
USD |
NASDAQ |
Sep 27, 16:00
1.32
-0.01
(-0.75%)
After-Hours: 20:00
Akebia Therapeutics EPS Diluted (Annual): -0.28 for Dec. 31, 2023
EPS Diluted (Annual) Chart
Historical EPS Diluted (Annual) Data
Date | Value |
---|---|
December 31, 2023 | -0.28 |
December 31, 2022 | -0.52 |
December 31, 2021 | -1.70 |
December 31, 2020 | -2.78 |
December 31, 2019 | -2.36 |
December 31, 2018 | -2.47 |
Date | Value |
---|---|
December 31, 2017 | -1.69 |
December 31, 2016 | -3.60 |
December 31, 2015 | -2.29 |
December 31, 2014 | -8.04 |
December 31, 2013 | -3.584 |
December 31, 2012 | -1.137 |
Earnings per Share Definition
Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.
EPS Diluted (Annual) Range, Past 5 Years
-2.78
Minimum
2020
-0.28
Maximum
2023
-1.528
Average
-1.70
Median
2021
EPS Diluted (Annual) Benchmarks
Corcept Therapeutics Inc | 0.94 |
Bioventus Inc | -2.49 |
Eli Lilly and Co | 5.80 |
Pfizer Inc | 0.37 |
Cara Therapeutics Inc | -2.19 |